Gene expression profiling of Japanese psoriatic skin reveals an increased activity in molecular stress and immune response signals

Journal of Molecular Medicine

Volumn 83, Issue 12, 2005, Pages 964-975

  Kulski, Jerzy K ^a,b   Kenworthy, William ^a   Bellgard, Matthew ^a   Taplin, Ross ^a   Okamoto, Koichi ^b   Oka, Akira ^b   Mabuchi, Tomotaka ^b   Ozawa, Akira ^b   Tamiya, Gen ^b   Inoko, Hidetoshi ^b,c,d,e,f  

^a MURDOCH UNIVERSITY   (Australia)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKAI UNIVERSITY   (Japan)

^d INSTITUTE OF CHEMISTRY AND CHEMICAL TECHNOLOGY   (Mongolia)

^e Harping University School of Medicine   (China)

^f GenoDive Pharma Inc   (Japan)

Author keywords

Gene expression; Immune responses; Interferon responses; Protein degradation; Psoriasis; Skin

Indexed keywords

GENE PRODUCT; INTERFERON; PROTEINASE; PROTEINASE INHIBITOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR JUNB; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CELLULAR IMMUNITY; CYTOSKELETON; DATA ANALYSIS; DISEASE MARKER; DNA DETERMINATION; DNA MICROARRAY; EPIDERMIS CELL; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNITY; JAPAN; MALE; NUCLEOTIDE SEQUENCE; PROTEIN DEGRADATION; PSORIASIS; SKIN BIOPSY; STATISTICAL ANALYSIS; STUDENT T TEST; T LYMPHOCYTE; UPREGULATION;

ADULT; BIOPSY; CASE-CONTROL STUDIES; DOWN-REGULATION; GENE EXPRESSION PROFILING; HUMANS; INTERFERONS; JAPAN; MALE; PSORIASIS; SKIN; STRESS; UP-REGULATION;

EID: 28544442794     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-005-0721-x     Document Type: Article

References (44)

1. Schon MP, Boehncke W-H (2005) Psoriasis. N Engl J Med 352:1899-1912
2. Weedon D (2002) Skin pathology, 2nd edn. Churchill Livingstone, London
3. Barker JNWN (1991) The pathophysiology of psoriasis. Lancet 338:227-230
4. McKenzie RC, Sabin E (2003) Aberrant signaling and transcription factor activation as an explanation for the defective growth control and differentiation of keratinocytes in psoriasis: a hypothesis (viewpoint). Exp Dermatol 12:337-345
5. Nestle FO, Conrad C, Tun-Kyi A, Homey B, Gombert M, Boyman O, Burg G, Lu Y-J, Gilliet M (2005) Plasmacytoid predendritic cells initiate psoriasis through interferon-α production. J Exp Med 202:135-143
6. Van der Fits L, van der Wel LI, Laman JD, Prens EP, Verschuren MCM (2003) In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-α. sensitivity is unaltered. J Invest Dermatol 122:51-60
7. Bowcock AM, Shannon W, Du F, Duncan J, Cao K, Aftergut K, Catier J, Fernandez-Vina M, Menter A (2001) Insights into psoriasis and other inflammatory diseases from large scale gene expression studies. Hum Mol Genet 10:1793-1805
8. Oestreicher JL, Walters IB, Kikuchi T, Gilleaudeau P, Surette J, Schwertschlag U, Domer AJ, Krueger JG, Trepicchio WL (2001) Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling. Pharmacogenomics J 1:272-287
9. Zhou X, Krueger JG, Kao M-CJ, Lee E, Du F, Menter A, Wong WH, Bowcock AM (2003) Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. Physiol Genomics 13:69-78
10. Nomura I, Gao B, Boguniewicz, Darst MA, Travers JB, Leung DYM (2003) Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol 112:1195-1202
11. Van de Kerkhof PC, Gerritsen MJ, de Jong EM (1996) Transition from symptomless to lesional psoriatic skin. Clin Exp Dermatol 21:325-329
12. Yip SY (1984) The prevalence of psoriasis in the Mongoloid race. J Am Acad Dermatol 10:965-968
13. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, Mittmann M, Wang C, Kobayashi M, Horton H, Brown EL (1996) Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 14:1675-1680
14. Pontius JU, Wagner L, Schuler GD (2003) UniGene: a unified view of the transcriptome. In: The NCBI handbook. National Center for Biotechnology Information, Bethesda
15. Liu WM, Mei R, Di X, Ryder TB, Hubbell E, Dee S, Webster TA, Harrington CA, Ho MH, Baid J, Smeekens SP (2002) Analysis of high density expression microarrays with signed-rank call algorithms. Bioinformatics 18:1593-1599
16. Hubbell E, Liu WM, Mei R (2002) Robust estimators for expression analysis. Bioinformatics 18:1585-1592
17. Liu G, Loraine AE, Shigeta R, Cline M, Cheng J, Valmeekan V, Sun S, Kulp D, Siani-Rose MA (2003) NetAffx: affymetrix probesets and annotations. Nucleic Acids Res 31:82-86
18. Rodriguez LG, Guan JL (2005) 14-3-3 regulation of cell spreading and migration requires a functional amphipathic groove. J Cell Physiol 202:285-294
19. Higashi Y, Fuda H, Yanai H, Lee Y, Fukushige T, Kanzaki T, Strott CA (2004) Expression of cholesterol sulfotransferase (SULT2B1b) in human skin and primary cultures of human epidermal keratinocytes. J Invest Dermatol 122:1207-1213
20. Boyman O, Hefti HP, Conrad C, Nickoloff BJ, Suter M, Nestle FO (2004) Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumour necrosis factor-α. J Exp Med 199:731-736
21. Nickoloff BJ (2001) Creation of psoriatic plaques: the ultimate tumor suppressor pathway. A new model for an ancient T-cell-mediated skin disease (viewpoint). J Cutan Pathol 28:57-64
22. Kose K, Utas S, Yazici C, Akdas A, Kelestimur F (2001) Effect of propylthiouracil on adenosine deaminase activity and thyroid function in patients with psoriasis. Br J Dermatol 144:1121-1126
23. Cheng N, Brantley DM, Liu H, Lin Q, Enriquez M, Gale N, Yancopoulos G, Cerretti DP, Daniel TO, Chen J (2002) Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis. Mol Cancer Res 1:2-11
24. Bridge AJ, Pebernard S, Ducraux A, Nicoulaz AL, Iggo R (2003) Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet 34:263-264
25. Izmailova E, Bertley FM, Huang Q, Makori N, Miller CJ, Young RA, Aldovini A (2003) HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages. Nat Med 9:191-197
26. Chin KC, Cresswell P (2001) Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proc Natl Acad Sci U S A 98:15125-15130. Erratum in Proc Natl Acad Sci U S A 99:2460
27. Kumar M, Carmichael GC (1998) Antisense RNA: function and fate of duplex RNA in cells and higher eukaryotes. Microbiol Mol Biol Rev 62:1415-1434
28. Behera AK, Kumar M, Lockey RF, Mohapatra SS (2002) 2′-5′ Oligoadenylate synthetase plays a critical role in interferon-gamma inhibition of respiratory syncytial virus infection of human epithelial cells. J Biol Chem 277:25601-25608
29. Jayan GC, Casey JL (2002) Inhibition of hepatitis delta virus RNA editing by short inhibitory RNA-mediated knockdown of ADAR1 but not ADAR2 expression. J Virol 76:12399-12404
30. Haque MA, Li P, Jackson SK, Zarour HM, Hawes JW, Phan UT, Maric M, Cresswell P, Blum JS (2002) Absence of gamma-interferon-inducible lysosomal thiol reductase in melanomas disrupts T cell recognition of select immunodominant epitopes. J Exp Med 195:1267-1277
31. Phan UT, Lackman RL, Cresswell P (2002) Role of the C-terminal propeptide in the activity and maturation of gamma-interferon-inducible lysosomal thiol reductase (GILT). Proc Natl Acad Sci U S A 99:12230-12298
32. Pernet I, Reymermier C, Guezennec A, Branka JE, Guesnet J, Perrier E, Dezutter-Dambuyant C, Schmitt D, Viac J (2003) Calcium triggers beta-defensin (hBD-2 and hBD-3) and chemokine macrophage inflammatory protein-3 alpha (MIP-3alpha/CCL20) expression in monolayers of activated human keratinocytes. Exp Dermatol 12:755-760
33. de Saint-Vis B, Vincent J, Vandenabeele S, Vanbervliet B, Pin JJ, Ait-Yahia S, Patel S, Mattel MG, Banchereau J, Zurawski S, Davoust J, Caux C, Lebecque S (1998) A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity 9:325-336
34. Aractingi S, Briand N, Le Danff C, Viguier M, Bachelez H, Michel L, Dubertret L, Carosella ED (2001) HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells? Am J Pathol 159:71-77
35. Hilt W, Wolf DH (1996) Proteasomes: destruction as a programme. Trends Biochem Sci 21:96-102
36. Tanaka K, Kasahara M (1998) The MHC class I ligand-generating system: roles of immunoproteasomes and the interferon-gamma-inducible proteasome activator PA28. Immunol Rev 163:161-176
37. Yao T, Cohen RE (2002) A cryptic protease couples deubiquitination and degradation by the proteasome. Nature 419:403-407
38. Rock KL, Goldberg AL (1999) Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu Rev Immunol 17:739-779
39. Iizuka H, Takahashi H, Honma M, Ishida-Yamamoto A (2004) Unique keratinization process in psoriasis: late differentiation markers are abolished because of the premature cell death. J Dermatol 31:271-276
40. Angel P, Karin M (1991) The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochim Biophys Acta 1072:129-157
41. Beal MJ, Falciani F, Ghahramani Z, Rangel C, Wild DL (2005) A Bayesian approach to reconstructing genetic regulatory networks with hidden factors. Bioinformatics 21:349-356
42. Bakiri L (2000) Cell cycle-dependent variations in c-Jun and Junb phosphorylation: a role in the control of cyclin D1 expression. EMBO J 19:2056-2068
43. Johansen C, Kragballe K, Rasmussen M, Dam TN, Iversen L (2004) Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with non lesional psoriatic skin. Br J Dermatol 151:600-607
44. Szabowski A, Maas-Szabowski N, Andrecht S, Kolbus A, Schorpp-Kistner M, Fusenig NE, Angel P (2000) C-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin. Cell 103:745-755